Distribution of Primary Resistance Mutations in Saint Petersburg in Patients with Chronic Hepatitis C

The advent of direct-acting antiviral drugs (DAAs) was a breakthrough in the treatment of patients with chronic hepatitis C, yet high viral replication errors can lead to the development of resistance associated variants (RAVs). Thus, assessment of RAV in infected patients is necessary to monitor tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Valutite, Diana, Ostankova, Yulia, Semenov, Alexandr, Lyalina, Liudmila, Totolian, Areg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139387/
https://www.ncbi.nlm.nih.gov/pubmed/35626210
http://dx.doi.org/10.3390/diagnostics12051054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139387/
https://www.ncbi.nlm.nih.gov/pubmed/35626210
http://dx.doi.org/10.3390/diagnostics12051054

Ejemplares similares